UC stroke experts present at international conference
February 7, 2024
University of Cincinnati neurology experts are presenting research at the International Stroke Conference 2024, Feb. 7-9 in Phoenix, Arizona.
February 7, 2024
University of Cincinnati neurology experts are presenting research at the International Stroke Conference 2024, Feb. 7-9 in Phoenix, Arizona.
February 6, 2024
Cincinnati's WLWT-TV highlights the legacy of UC alumna Marian Spencer.
February 6, 2024
The Ariel Quartet returns to the stage 7:30 p.m. Tuesday, Feb. 13 in Robert J. Werner Recital Hall at CCM. Titled “Cetera Desunt: The rest is missing,” the program features the eponymous string quartet by Lera Auerbach, as well as the composer’s string quartet No. 10, “Frozen Dreams” and Schubert’s beloved “Trout” Quintet. Tickets are on sale through the CCM Box Office.
February 6, 2024
The Ohio Department of Higher Education has awarded $1.5 million in new funding to provide essential resources and new initiatives to support student mental health and well-being at the University of Cincinnati.
February 6, 2024
A new University of Cincinnati trial, in partnership with Spark Biomedical, will test a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
February 2, 2024
Building a diverse blood donor base in greater Cincinnati – The unique impact of minority blood donors
February 2, 2024
Satish Madala, MD, of the UC Division of Pulmonary, Critical Care and Sleep Medicine, was interviewed by Spectrum News about research he lead that identified a key molecule in the treatment of asthma.
February 1, 2024
Hoxworth Blood Center honored by City of Cincinnati leadership for 85 years of serving the greater Cincinnati community
January 31, 2024
The University of Cincinnati Blue Ash College's Jennifer Wells was a panelist on WVXU's Cincinnati Edition discussing a new drug being developed designed to extend the lives of dogs.
January 31, 2024
The percentage of females with kidney disease who use contraception is much lower than the rate of contraceptive use by females in the general population, according to a new study from researchers at the University of Cincinnati.